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Abstract 
 
Cannabis is the most widely used illicit drug, worldwide and also in Afghanistan. 
According to United Nation Office for Drug and crime (UNODC) Afghanistan Cannabis 
survey (2009), more than half of all drug users interviewed in Afghanistan had used 
cannabis in their life time. In this survey around 630,000 people, mostly men, were 
documented as cannabis users. On the other hand, cannabis life time use amongst regular 
female drug user was 40%. The annual prevalence of cannabis use was 8.1 percent in 
male and 0.2 percent in female populations (UNODC Afghanistan Cannabis survey 
2009). In Afghanistan cannabis is most commonly used amongst various groups of 
individuals, including public transport and truck drivers, and law enforcement personnel, 
such as Afghan National Police and Afghan National Army recruits. According to a 
Government Accountability Report for the United States Congress in March 2010, the 
percentage of Afghan Police recruits who tested positive for drug use, (i.e., marijuana, 
hashish and opiates) was 12-40% (Nordland & Wafa, 2010).  Cannabis use has been 
linked to a myriad of adverse health outcome included but not limited to, increased risk 
of schizophrenia, impairment of cognitive functioning, deterioration of motor skills, 
weakening of driving skills, adverse pregnancy outcome and increased risk of 
cardiovascular and respiratory diseases (Kalant, 2004). The aim of this paper is to 
highlight cannabis production, use and adverse health outcomes in Afghanistan and to 
propose recommendations for cannabis control and reversal of its negative health 
outcomes.  
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Chapter I 
1.1 Introduction 
 
According to the first-ever United Nation Office for Drug and Crime (UNODC) 
report, cannabis production is overtaking opium in Afghanistan (Afghanistan Cannabis 
Survey 2009). This fact earmarks Afghanistan as a country with the largest production of 
cannabis. According to the UNODC Afghanistan Cannabis survey (2009), more than half 
of all drug users interviewed in Afghanistan had used cannabis in their life time. In this 
survey around 630,000 people, mostly men, were documented as cannabis users. On the 
other hand, cannabis life time use amongst regular female drug user was 40%. The annual 
prevalence of cannabis use was 8.1 percent in male and 0.2 percent in female population 
(UNODC Afghanistan Cannabis survey 2009). In Afghanistan, Cannabis is most 
commonly used amongst various groups of individuals, including public transport 
drivers, and law enforcement personnel including Afghan National Police and Afghan 
National Army recruits. Based on a Government Accountability Report for the United 
States Congress, the upper range of Afghan Police recruits who tested positive for drug 
use (i.e., marijuana, hashish and opiates) was 40 % (Nordland & Wafa, 2010) 
This widely used drug is not insipid; studies have indicated the epidemiologic link 
between cannabis use and risk of schizophrenia. Various studies have documented the 
adverse effect of cannabis use and driving skills impairment (Kalant, 2004). Cannabis 
smokers have showed increased risk of chronic airway inflammation and airway cancer. 
Numerous studies have found the risk of physical and psychological dependency in a 
significant portion of cannabis users. Early cannabis use, especially, weekly or daily use 
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predicts future dependence. It is documented that around 7-10 percent of regular cannabis 
users were both physical and psychological cannabis dependent. The impact of cannabis 
use on cognitive included permanent impacts on recall, information processing, and 
major brain tasks in fetus of pregnant cannabis female users (Kalant, 2004). 
1.2 Forms of Cannabis  
 
Cannabis is used in various forms: herbal cannabis, this form is used as desiccated 
leaves and flowering tops, also known as “ganja, or weed” or “cannabis resin”; the 
second form is the squeezed secretion of the herb, known as hashish or in local language 
known as ‘charas’; and the third form is the oil cannabis which is a blend made from 
concentration or extraction of active constituent of the herb (UNODC Afghan Drug 
Survey Executive Summary 2009).  
Cannabis is the largest produced illicit drug globally and is seen nearly in every 
country worldwide.  Almost one fourth of all the worlds’ cannabis is produced in Africa, 
particularly in Morocco, South Africa, Lesotho, Swaziland, Malawi, Nigeria, Ghana, 
Senegal, Gambia, Kenya and Tanzania. In addition, North and South America produce 
less than half of global cannabis demands (UNODC Afghan Drug Survey Executive 
Summary 2009). 
In term of quantity and geography, cannabis herb is the most widely smuggled 
illicit drug worldwide. Around 70 % of world’s cannabis is seized in North America, 
especially, in Mexico and United States, followed by 11 % and 10% in Africa and in 
South America, respectively. Cannabis resin is the second most trafficked drugs 
worldwide. Afghanistan has started recently to exceed Morocco in cannabis production. 
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Afghanistan’s cannabis has also been a major alternative for opium crops. Due to less 
laborious work, low irrigation needs, high yields and lucrative markets, cannabis is 
substituting opium in Afghanistan (UNODC Afghan Drug Survey Executive Summary 
2009). 
1.3 Prevalence of Cannabis Use Worldwide 
 
Cannabis use is estimated to be between 125 million and 203 million people 
worldwide (UNODC, World Drug Report, 2010). In 2009 the estimate of cannabis use in 
population aged between 15 and 64 years was 2.8 to 4.5 percent worldwide.  Cannabis 
use in North America has remained unchanged; but has increased slightly over the past 
four years in the United States (UNODC, World Drug Report, 2010).  Annual prevalence 
of cannabis use in North America is around 10.7 percent amongst people age 15-64; 
however, cannabis use prevalence amongst youth has been increased over the past four 
years (cannabis review). According to UNODC Afghanistan Cannabis survey (2009), 
Afghanistan’s cannabis use prevalence in 2009 was 8.1 percent in male and 0.2 percent in 
female population. According to this report around 60 percent of all drug users 
interviewed in Afghanistan had the history of cannabis use in their life time whereas 40 
percent of women drug users had the history of cannabis use in the past. In addition, this 
survey had documented approximately 630,000 people, mostly men, as cannabis users. 
1.4 Afghanistan overview  
 
Afghanistan is a land locked country about the size of Texas, is located in south 
Asia and sometimes being described as located in the heart of Asia linking South and 
East Asia with Central and Western Asia. Afghanistan borders Uzbekistan, Tajikistan, 
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and Turkmenistan  on the north, China on the northeast, Pakistan on the south and east 
and Iran on the west (Afghanistan Overview). Afghanistan covers 652,230 sq km of area. 
The estimated population will be 31,108,077 by July 2013 (CIA - The World Factbook). 
Afghanistan is divided into 34 provinces and 397 Districts (Afghanistan Overview).  
Afghanistan is world’s 41st biggest country in size. Kabul is the capital of 
Afghanistan, which is located in the central part of Afghanistan in Kabul province. Due 
to its strategic location at the crossroads of the major trade routes, Afghanistan has been 
the place for commerce and thus attractive to invaders since the sixth century BC.  
Afghanistan is divided by Hindokush Mountains into three main regions: 1) 
central highlands that account for roughly 60% of the country’s area, 2) the southwestern 
region, which include 25% of the land; 3) and the minor northern grasslands areas, which 
covers the country’s most productive land.  Average life expectancy at birth for total 
population is 50.11 years, male: 48.81 years, and female: 51.47 years. Afghanistan 
natural resources include “natural gas, petroleum, coal, copper, chromite, talc, barites, 
sulfur, lead, zinc, iron ore, salt, precious and semiprecious stones” (CIA - The World Fact 
book). Due to four decades of war and turmoil in the country, these resources have not 
been properly explored and utilized. 
1.5 Economy 
 
           Afghanistan’s main economy is dependent on agriculture which generates two 
thirds of national income and employs almost 85 percent of the country’s population. 
Most land cultivation is carried out in oases and valleys, and the characteristic of live-
stock breeding is in a semi-nomadic form. Main branch of agriculture is relied on 
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livestock breeding; it represents almost one third of agricultural production. The 
country’s crop production is dependent on irrigated lands. Half of these lands are still 
faced with shortage of water. Current irrigation systems of Afghanistan was established 
after 1945 (Afghanistan Overview). Afghanistan’s main crop is wheat, corn and rice, but 
due to continuing war and economic constrain these crops have been replaced by opium 
and cannabis, especially, in northern and southern regions. 
Afghanistan’s map 
 
Source: - http://www.173rdairborne.net/images/afg_ad1.gif 
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1.6 Geography of Cannabis Production and Use in Afghanistan   
 
According to the Ministry of counter narcotic and the United Nation Office for 
Drug and Crime “MCNUNODC” cannabis survey (2011), 23 provinces in Afghanistan 
were identified as high risk areas for cannabis cultivation. Ground information from 11 
other provinces indicated that cannabis cultivation either did not exist or was negligible- 
limited to kitchen garden or other form of small-scale – cultivation.  
The survey was conducted between July and September 2011 in 1,500 villages 
where farmers and headmen were interviewed, and was substantiated by yield studies and 
satellite image interpretations. The yield observation study was undertaken in December 
2011-January 2012, when the processing of cannabis resin production took place and this 
study was preceded by headmen and farmers interview during the villages’ surveys. The 
overall cannabis area estimate was based on the interpretation of 155 very high-resolution 
satellites images and village survey (Afghanistan Cannabis Survey 2011) 
The cannabis cultivated areas in 2011 were estimated to be 12,000 hectares (8,000 
– 17,000 ha). This result was slightly lower compared to 2010 estimate which was 9,000-
29,000 ha. The covered areas that were included in estimation were due to large scale 
mono-crop cannabis cultivation and “commercial” production. Small-scale cultivation, 
“such as in kitchen gardens, flower pots, along the walls of compounds, along the 
boundaries of fields, “wild cannabis” or cannabis intercropped with other crops in the 
same field at the same time, is not part of the area estimates of this survey” (Afghanistan 
Cannabis Survey 2011). Cannabis was found to be cultivated in 21 provinces out of 23 
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high risk provinces for cannabis cultivation. Out of 21 provinces where cannabis was 
found to be cultivated, 14 provinces were substantiated by satellite images and 7 
provinces were covered by the villages’ surveys only. In these surveys more than one 
third of cannabis was cultivated in the southern region. This difference by region was due 
to opium cultivation; however, cannabis cultivation was also found in several poppy free 
provinces, but, there was an explicit geographic association between cannabis and opium 
cultivation in provincial level (Afghanistan Cannabis Survey 2011). 
Most commercial Cannabis cultivation in 2011, similar to 2009 and 2010, was in 
the southern region, where most of opium (78%) was also cultivated.  Daykundi, 
Helmand, Kandahar, Urozgan and Zabul provinces were the main southern provinces 
where cannabis was cultivated. There was a clear geographical association between 
opium and cannabis cultivation at the provincial level. Similar association existed at a 
household level with almost two thirds of cannabis-growing households (58%) also 
reported poppy cultivation in the preceding season (Afghanistan Cannabis Survey 2011). 
Commercial Cannabis Cultivation Status, by Province, 2011 
 
 
 
 
 
 
 
Source: - MCN-UNODC Afghanistan Cannabis Survey, 2011 
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1.7 Cannabis Use  
 
Similar to regional differences, northern and southern parts of Afghanistan have 
the highest prevalence of cannabis use and these areas are also the major producers of 
cannabis in Afghanistan (Afghan-Drug-Survey-2009-Executive). Men are the major 
cannabis users in Afghanistan; in 2009, 8.1 percent of men were documented as cannabis 
users. The prevalence has been stable for the last four years; in 2005 the prevalence of 
cannabis use was 8 percent and only 0.1 percent increment has been observed over the 
course of past four years. Around 70 percent of these cannabis users reported regular 
daily cannabis use while 25 percent reported 2 to 4 days in a week in the past month. In 
contrast, the number of women cannabis users was much smaller than men cannabis 
users; the prevalence of women cannabis users was 0.2 percent, which has doubled since 
2005. Twenty five percent of women who used cannabis reported daily cannabis use, 50 
percent  2 to 4 days a week and the remaining 25 percent reported 1 day a week of 
cannabis use,  (Afghan-Drug-Survey-2009-Executive).  
The rate of cannabis dependency was higher in men cannabis users than in 
women cannabis users. The rate of cannabis dependency was three times more common 
in men than in women cannabis users.  The use of cannabis, in comparison to other illicit 
drugs, started at early age around 18-19 years, whereas the mean age for heroin use was 
24 years of age. Most cannabis users were educated, 50 percent of cannabis users in 
Afghanistan reported having primary education and around 30 percent had secondary 
education. In contrast, other drug users, such as opium and heroin users, were mainly 
uneducated and illiterate.  Similarly, cannabis users had fewer psychosocial problems 
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than opium and heroin users in Afghanistan. However, cannabis users still face some 
kinds of physical, psychological and relationship problems due to cannabis use   (Afghan-
Drug-Survey-2009-Executive).  
Cannabis Use by region in Afghanistan, 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source:-  Afghan Drug Survey Executive Report 2009 
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Chapter II 
2.1 Review of Literature 
 
Cannabis use has been linked to myriad negative health outcomes; studies have 
shown the epidemiologic link between cannabis use and schizophrenia (Kalant, 2004). In 
several studies the negative impacts of cannabis use and impairment of driving and motor 
skills have been highlighted. In various studies the risk of chronic airway inflammation 
and cancer due to Cannabis smoking has also been stressed. Numerous studies have 
showed the risk of physical and psychological dependency in a significant portion of 
cannabis users. Early cannabis use, especially, weekly or daily use has predicted future 
dependence. It has been documented that around 7-10 percent of regular cannabis users 
have been both physical and psychological cannabis dependent. Cognitive impairment 
included permanent recall issues, processing of information and major function of fetus 
brain of pregnant cannabis users (Kalant, 2004). 
2.2 Cannabis Use and Risk of Schizophrenia  
 
Psychosis is defined as mental state characterized by the following features: 
delusions, which are false beliefs; hallucinations, which are sensation of things in the 
absence of true environmental stimulation, such as hearing voices and seeing objects 
without true stimuli; and gross disorganization of speech and/or behavior which does not 
make sense (American Psychiatric Association 2000).  
Discrete psychotic disorders that can be experienced at any time in life should not 
be considered as psychotic disorder; such indications may be clinically insignificant, 
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especially, when they are transitory and brief. However, when these symptoms are 
severe, numerous in number and occurring simultaneously and persist for longer period 
of time, then such psychotic disorder can be diagnosed as schizophrenia. To diagnosis 
schizophrenia the following conditions should exists. (a) In addition to ‘negative 
symptoms’, which include a number of symptoms such as emotional instability, mutism 
(lack of speech), and/or absence of motivation; presence of two or more distinguishing 
symptoms “(delusions, hallucinations, disorganized speech, grossly disorganized or 
catatonic behavior)”,  for a considerable  period of time in a month; (b) loss of function in 
social or occupational settings;  and (c) persistence of these signs constantly for at least 
six months (American Psychiatric Association, 2000) 
Increasing use of cannabis has been seen amongst schizophrenic patients. in 
recent assessment of more than 50 treatment studies, amongst patient with psychosis, 
prevalence of cannabis use was 29.3 percent compared to 4 percent in the general US 
population (B. Green, Young, & Kavanagh, 2005). In addition, cannabis use has been 
shown to be linked with two time increase in odds ratio of developing schizophrenia and 
associated disorders in prospective studies (Arseneault, Cannon, Witton, & Murray, 
2004). In addition, the link between cannabis sue and acceleration of schizophrenia onset 
has been noticed in retrospective studies (Hambrecht & Häfner, 2000). Despite the 
ambiguous mechanism of psychosis, these studies suggest the important role of cannabis 
use in psychosis causation. In one study, the likelihood of cannabis use and stable 
neurological changes in schizophrenic patient was not found; however, the transient 
adverse outcome of neurochemical effects was found which was prominent in people 
with genetically vulnerability to psychosis (Foti, Kotov, Guey, & Bromet, 2010).  
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The relationship of cannabis use and schizophrenia and/or psychotic symptoms 
has been noticed for some time. In a study conducted by Hambrecht and Hafner (2000) 
the relationship of cannabis use and psychotic symptoms was found in bunch of analysis 
in early psychosis patients. Several potential types of correlation between cannabis use 
and psychotic symptoms and/ or schizophrenia were proposed by them. The use of 
cannabis was proposed to reduce the vulnerability threshold of schizophrenia and 
enhance the susceptibility to psychosis in people without known genetic liability to 
schizophrenia. The dose response association between quantity of cannabis used in 
adolescence and the following risk of emerging schizophrenia was studied by Andreasson 
et al (1987). In more recent studies that controlled for other drug use such as 
amphetamine and personality trait, it was concluded that 13% of schizophrenia might be 
prevented if cannabis could be removed from the ‘schizophrenia equation’ (Cohen, 
Solowij, & Carr, 2008).  
Van Os et al (2002) in a balanced prospective study found that in people, who 
were free from psychotic symptoms, the length of lifetime exposure to cannabis was a 
significant risk factor for the developing of psychosis. In people with no genetic liability 
to psychosis, cannabis use was linked in up to 50 percent of cases to develop psychosis.  
In another study done by Arsenault et al. (2003) it was found that use of cannabis 
increased the risk of developing schizophrenic symptoms after controlling for symptoms 
of pre-existing psychosis and it was also noted that the commencement of cannabis use at 
early age (prior age 15) could pose great risk for developing schizophrenia (Arseneault et 
al., 2002). Cohen and his colleague mention that one reason for this can be the 
neurodevelopmental process in which the cognitive, developmental, emotional, and 
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behavioral measures shift to adulthood and can easily be affected by cannabis use, 
specifically, frontal and limbic systems would be more sensitive to these changes (Cohen 
et al., 2008).  
In many cohort studies the association between cannabis use and 
psychosis/schizophrenia, over the past several years, has engrossed substantial 
consideration in the research, media and the community (David M Fergusson, Boden, & 
Horwood, 2006). Cannabis use is causally related to psychotic disorders such as 
schizophrenia and often has been interpreted as causative factor in these studies (Smit, 
Bolier, & Cuijpers, 2004). The contributory part of cannabis use in psychosis has been 
indicated in many reviews or the links between such relationship have often not been 
excluded (Moore et al., 2007).  
However, some uncertainties that whether cannabis use contributes to psychotic 
disorders emergence, due to some mythological limitations, are controversial. At the 
same time as few published cohort studies have evaluated the strengths and weaknesses 
of these methodologically diverse cohort studies, the comparative qualities and 
weaknesses might impact the interpreted relationship of cannabis use and psychosis 
(McLaren, Silins, Hutchinson, Mattick, & Hall, 2010).  
For the evidence to demonstrate that a particular association is casual, these need to be 
shown: 
1. Strength of correlation. 
2. Consistency 
3. Temporality 
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4. Biological gradient 
5. Coherence. 
6. Specificity 
7. Plausibility  
8. Analogy 
 (McLaren et al., 2010). 
2.3 Swedish Conscript Study 
The development of psychosis was found in the first cohort study which predicted 
cannabis use and subsequent psychosis in a sample male Swedish Conscript. These 
conscripts who were evaluated for substance use and psychiatric diagnosis at age 18 were 
tracked for more than 10-year period inpatient admission for schizophrenia (Andréasson, 
Allebeck, Engström, & Rydberg, 1987). At age 33 those who used cannabis 50 times or 
more had six times more rate of hospitalization for schizophrenia than those who did not 
use cannabis. In addition, the rate of hospitalization for schizophrenia was three times 
more in those who had used cannabis between 10 and 50 times.  However, when some 
confounders such as, “social and family background, and other substance use were 
controlled, the rate of hospitalization for schizophrenia amongst those who had used 
cannabis less than 10 times was reduced to 2.3 (95% CI: 1.0–5.3) and was no longer 
statistically significant. The adjusted odds ratio for those who had used cannabis more 
than 50 times was not reported” (McLaren et al., 2010) 
Cannabis use 1-10 times (relative risk: 1.5, 95% CI: 0.6–3.3) was less significant 
as variable than others which best predicted schizophrenia. Psychiatric diagnosis at the 
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baseline and separated parents were the variables that best predicted schizophrenia. The 
duration of cannabis use was not covered in this study; however, during the follow-up 
period at conscription study cannabis use was strongly linked with later treatment for 
cannabis and other substance use (McLaren et al., 2010).  
. 
                Pre-existing psychotic or other psychiatric signs at baseline were not measured 
in the study and it is difficult to decide whether cannabis use predict psychotic symptoms 
or not. It is also challenging to account premorbid personality traits for both cannabis use 
and development of schizophrenia. Other potential confounding that were serious 
psychogenic substances such as amphetamine was also not controlled for (McLaren et al., 
2010).  
         Another study with relatively longer follow-up period was undertaken as re-
analysis, in which stimulants and other substance use including alcohol were controlled; 
cannabis persisted as predictive factor for schizophrenia in a dose-dependent manner. The 
rate of hospitalization, because of schizophrenia, was  three times more for those who had 
used cannabis 50 times or more at age 18 than those who did not use cannabis (Zammit, 
Allebeck, Andreasson, Lundberg, & Lewis, 2002). An inclusive extent of premorbid 
social integration, which did not impact the association between cannabis use and 
schizophrenia, was included in this study  (McLaren et al., 2010). 
A multi-site survey of population was launched in the United States between 1980 
and 1984 in which the presence of psychotic disorders were measured through the 
Diagnostic Interview Schedule (DIS) (Tien & Anthony, 1990). This survey, which 
measured substance use, social and demographic characteristics, was launched at the 
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baseline and at one year follow-up. For the evaluation of cannabis use and the risk of 
psychotic symptoms, participants with one or two symptoms at baseline were disqualified 
and ‘cases’ (subjects with at least single psychotic symptom at follow-up year) were 
compared with controls (i.e., those without psychotic experiences at follow-up). After 
controlling for social and demographic factors (e.g., sex, education, marital status, and 
occupation), baseline substance use (regular cocaine and alcohol use) and psychiatric 
disorders, overall, 477 cases were matched with 1818 controls whose age range was 
between 18 and 49. This survey showed cannabis use to be linked with two-fold risk of 
psychotic symptoms one year later   (McLaren et al., 2010). 
The Netherlands Mental Health Survey and Incidence Study (NEMESIS)  found 
in population cohort of cannabis users at baseline whose age range was between 18 and 
64 years, the experience of mild psychotic symptoms at follow-up (three years later, OR: 
2.11, 95% CI: 0.78–5.71, not significant). More significantly, after controlling for age, 
sex, socioeconomic status, and other drug use, 17 times more clinically significant 
psychotic symptoms were reported by them three years later (OR: 16.93, 95% CI: 3.33–
86.13); and they were over 10 times more likely to need care for psychotic symptoms 
than those who did not use cannabis (van Os et al., 2002). 
In addition, the link between cannabis use and psychosis was dose dependent. 
Notably, those who were included in the NEMESIS sample, all of them were psychotic 
symptoms free at the baseline. Those who had psychotic symptoms at the baseline were 
studied separately and they showed stronger psychotic symptoms following cannabis use 
than those who did not use cannabis. The author concludes that the acute impact cannot 
predict the link between cannabis use and psychotic symptoms and adds that the 
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relationship between cannabis use and risk of psychotic symptoms is based on long-term 
cannabis use (McLaren et al., 2010). 
Cannabis use, at age 11, 15 and 18, and preceded Psychotic symptoms along with 
schizophrenic symptoms and diagnosis of schizophreniform disorder at age 26, were 
studied in a study known as “The Dunedin Multidisciplinary Health and Development 
Study” that has been running in New Zealand since the 1970 as the birth cohort study. In 
this study, 759 males and females born between 1972 and 1973 were studied for 
mentioned psychotic symptoms. Schezophreniform and schizophrenia are alike in terms 
of symptoms but the duration of symptoms differ; the duration of symptoms for 
schizophrenia is at least six months whereas the duration for schizophreniform symptoms 
is one month and it does not necessarily lead to occupational and socials issues 
(American Psychiatric Association, 2000). In this study, subjects who had started 
cannabis use at age 15, even after controlling for other drug use and childhood psychotic 
symptoms, had more symptoms of schizophrenia at age 26 than those who did not use 
cannabis. In addition, the link between schizophriniform diagnosis and cannabis use at 
age 15, but not 18, was noticed; however this association was weaker after controlling for 
childhood psychotic symptoms in the analysis (Arseneault et al., 2002).  
Another cohort study, known as the Dunedin birth cohort, proposed that genetic 
predisposition could lessen cannabis effects on psychosis risk. Those who had functional 
polymorphism of a gene (catechol-O-methyltransferase, or COMT), which involved in 
the dopamine system (the neurotransmitter system implicated in schizophrenia), were 10 
times more at the risk of developing schizophriniform disorders by age 26 than those who 
did not possess this gene (Caspi et al., 2005). The author reasoned that the environmental 
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risk factor, such as in this case adolescent cannabis use, was a prerequisite for 
development of psychosis amongst those who had the particular polymorphism. 
Increased risk of schizophriniform was not increased in participants who were  Val/Val 
allele and did not use cannabis (McLaren et al., 2010). This result has been failed to be 
replicated in a large case–control study by Zammit et al. (2007). 
It should be noted that psychotic patients can also use cannabis for the alleviation 
of some of their psychotic symptoms. However, self-medication hypothesis has not been 
shown in studies as the most plausible explanation for the relationship between cannabis 
use and psychosis. In a recent study in Australia the bidirectional relationship between 
psychotic patient and cannabis use was found. In this study relapse of psychotic 
symptoms was predicted with cannabis usage, and cannabis consumption relapse was 
predicted with psychotic relapse, regardless of medication and other drug use (Hides, 
Dawe, Kavanagh, & Young, 2006) 
2.4 The Effect of Cannabis Use on Vehicle Crashes 
 
Tetrahydrocanabinol (THC), an active ingredient found in cannabis, results in 
impairment of driving skills and this has been traditionally established in experimental 
and epidemiologic studies. The impairment of cognition, psychomotor function and 
actual driving performance in a dose related manner after cannabis use and concentration 
of THC has been repeatedly shown in experimental studies. These impairments were 
dose related; for instance, 300g/kg of THC had the same effect as of blood alcohol 
concentration (BAC) ≥0.05 g/dl, which in most European countries is the legitimate limit 
for driving under the influence. Higher doses of THC, i.e., >300 g/kg, which has not been 
systemically studied, may have stronger effect on driving impairment. THC had greater 
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impact on highly automated behaviors, such as road tracking control, than on complex 
driving skills that needed conscious control. The finding of epidemiological studies and 
experimental studies on the effect of cannabis (THC) on vehicle crashes is different. The 
findings of experimental studies have been reinforced by case-control studies, but 
capability studies have shown little proof about the link between cannabis use and vehicle 
motor crash. However, after determination of presence of an inactive metabolite of THC 
in the blood and urine of crashed drivers several days after smoking cannabis, most 
culpability surveys established link between previous cannabis use and vehicle crashes. 
In surveys which documented recent cannabis use by measuring THC in the blood of 
crashed drivers; the THC presence in the blood of crashed drivers, especially, at greater 
concentration, was linked to three to seven times more crashes than those who did not 
have THC concentration in their blood or did not use cannabis or alcohol. Recent 
cannabis use may increase the likelihood of crashes but old cannabis use does not, these 
findings have been suggested in these epidemiological studies. The findings of 
epidemiological studies and experimental research are the same concerning the effect of 
combined alcohol and cannabis use in traffic. The effects of combined use of alcohol and 
cannabis are greater than the individual use of either drug. They both, when used jointly, 
produced severe impairment of intellectual, psychomotor, and actual driving performance 
in experimental studies and heightened accident risk in epidemiologic analyses 
(Ramaekers, Berghaus, van Laar, & Drummer, 2004).  
The prevalence of cannabis use, THC concentration in the blood of drivers who 
had vehicle crash, has been reported to be between 4 and 14 percent. These findings are 
reported from the surveys in different localities (Ramaekers et al., 2004). However, 
20 
 
higher concentration of THC has been reported in young males in larger American cities 
post vehicle crashes (Williams, Peat, Crouch, Wells, & Finkle, 1985).   
The likelihood of crashes after the combined use of cannabis and alcohol are 
greater than the use of either drug alone. However, Lack of an appropriate control group 
further limits the findings in these studies. These studies only show the presence of these 
substances in the blood of drivers post (fatally) crashes. the absence of a control group, 
which can yield comparable data from general driving population, does not validate the 
prevalence measure of THC or other substances in causing traffic crashes  (Ramaekers et 
al., 2004). 
Despite showing the link between combined substance use, (i.e., alcohol and 
cannabis use and motor vehicle accident), culpability surveys do not show the increase 
rates of crashes after use of cannabis alone. However, culpability surveys show the 
association between cannabis use and crashes after finding higher concentrations of THC 
(Terhune et al., 1992). For instance, in two studies by Hunter et al., (1998) and Drummer 
et al., (2003), recent cannabis use was confirmed by THC concentration in the blood 
drivers post crashes. Both studies showed the link between higher concentration of THC 
and increase likelihood of crashes (Ramaekers et al., 2004).  
Similarly, case-control studies show a positive relationship between cannabis use 
and crashes. In a case-control study done by Mura et al. (2003), THC was compared 
among injured drivers and control subjects, who were recruited from emergency 
departments in six French hospitals. In this study, sample of 1,800 drivers, 900 cases and 
900 controls were studied. The cases were the drivers who entered the emergency 
department due to non-fatal accident and the controls were visitors of the same 
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emergency department due to non-traumatic reasons. Cases and controls were controlled 
for age and sex and when averaged overall all age groups, 10 percent of cases and 5 
percent of controls had THC >1 ng/ml, no other drug including alcohol was found in their 
blood. Fifteen percent of the cases and 6.7% of the controls had THC in their blood when 
they were considered for age 27 and younger and the odds ratio of 2.5 and a 95% CI 
ranging from 1.5 to 4.2 was noted. In cases that had both THC and alcohol (BAC > 0.05 
g/dl)  the OR was doubled (95% CI: 2.0–10.7) (Mura et al., 2003). 
In summary, dose related THC has been linked to the impairment of psychomotor 
function, and actual driving performance. THC at doses of up to 300 g/kg was 
comparable to the impairing effects of an alcohol level a BAC ≥ 0.05g/dl, which is the 
legal limit for driving under the influence in most European countries. The relationship of 
recent cannabis use and vehicles crashes has been documented, especially, at higher 
doses; however, there is no finding concerning past cannabis use and motor vehicle 
accidents.  Adverse effects of THC are more prominent in highly automated driving 
behavior, as compared to more complex driving tasks that require conscious control 
(Ramaekers et al., 2004). 
 
2.5 Cannabis as a Gateway Drug  
 
Gateway sequence can be an independent risk factor for substance use; for 
instance, one who is already on a drug is at greater risk for the subsequent use of another 
substance and this subsequent use can be explained by the sequence that one has entered 
rather than by opportunity for use (Kandel & Faust, 1975). Two types of evidence can 
support the gateway theory: the noted time order between uses; for instance, in most 
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cases prior cannabis use precedes the use of other illicit drugs (OID); and the strength of 
the relationship between cannabis use and other illicit drug use (Lessem et al., 2006).  
To propose that cannabis use can lead to the development of other illicit drugs in 
naturalistic studies is difficult, because randomization of subjects to the experimental 
conditions is often problematic. However, quite a few research studies have been 
launched to explore cannabis use as the cause of initiation of other illicit drugs in 
epidemiological samples. 
Shrout (1998) proposed that association, isolation, and direction are the conditions 
that establish causation. Therefore, indication of cannabis use, which links to the 
progression of other illicit drug use, even after controlling for other confounders, validate 
the condition of association and isolation; however, they cannot eliminate other 
unmeasured variables to be the causal factors. In addition, longitudinal studies owing to 
the temporal sequence of events (i.e. that cannabis use precedes other illicit drug use) can 
fulfill the condition for direction (Lessem et al., 2006). 
In a study by Yamaguchi and Kandel, (1984), despite controlling for other 
covariates, it was found that cannabis use was associated with use of other illicit drugs. 
Likewise,  Fergusson and Horwood, (2000) explored the prediction of cannabis use and 
subsequent other illicit drug use after controlling for family, social, educational, and 
behavioral background. They found that other illicit drug use was 59.2 times more likely 
in cannabis users, (who reported using cannabis on more than 50 occasions) than in non-
cannabis users.  
In another study by Lessem and his colleagues ( 2006),  it was found that young 
cannabis users were twice as likely to use illicit drugs that non-cannabis users. They 
23 
 
mentioned that shared environmental factors mediated much of the relationship between 
adolescent cannabis use and young adult drug users. In this study, the finding was stable 
even after controlling for familial environmental and other measured factors.  Mayet and 
his colleagues, (2012) found that cannabis use could tremendously increase the risk of 
initiation of other illicit drugs (OID). In their study they found that the risk of starting 
other illicit drugs amongst cannabis experimenter was 21 times, and amongst daily 
cannabis users was 124 times higher than in non-cannabis users.  They mentioned “the 
results of this study provide a confirmation of a stage process in drug use, mediated by 
cannabis and liable to lead to OID experiment. This is compatible with the literature on 
the gateway theory, but goes further by modeling the entire sequence of use. OID 
experiment could be a consequence of initial opportunity to use the more accessible illicit 
drug, cannabis.” (Mayet et al., 2012) 
 
2.6 Cannabis Use and Crime  
 
Several studies have indicated the link between cannabis use and a range of 
adverse social outcomes, such as poor educational attainment, unemployment, personal 
relationship issues, and reduced life satisfaction. However, some studies find 
inconsistencies in these outcomes and other studies question these findings.  Due to large 
mythological challenges and differences in study design (i.e., cross sectional studies and 
even in population based studies), it is hard to mitigate contributing confounding in this 
domain (Pedersen & Skardhamar, 2010). Nonetheless, the evolving idea in some studies 
indicates that the effects of cannabis use can be more pervasive than it was thought 
previously. During the last two decades, some attentions have been directed to cannabis 
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use and crime. The sophisticated link of cannabis use and crime has been addressed in a 
number of studies. In some studies conduct problems have been indicated as a risk factor 
for subsequent cannabis use while other studies have linked cannabis use with increased 
delinquent activity and crime (Pedersen & Skardhamar, 2010). 
 
 Pedersen and Skardhamar, (2010) found the strong relationship between cannabis 
use and later registered criminal charges in young adulthood. They mention that this 
finding was noted even after controlling for the following confounding varaibles, such as 
socio-economic background of family, support and monitoring role of parents, career and 
educational achievement, past criminal charges, conduct problems and history of living 
together and marriage. They further report similar findings after adjusting for alcohol and 
other illicit drug use. However, they reported insignificant findings of a link between 
cannabis use and criminal charges after eliminating all drug specific charges in their 
model. They conclude that “cannabis use in adolescence and early adulthood may be 
associated with subsequent involvement in criminal activity. However, the bulk of this 
involvement seems to be related to various types of drug-specific crime. Thus, the 
association seems to rest on the fact that use, possession and distribution of drugs such as 
cannabis is illegal. The study strengthens concerns about the laws relating to the use, 
possession and distribution of cannabis” (Pedersen & Skardhamar, 2010). 
In another study by Green and his colleagues (2010) the interaction of heavy 
adolescent cannabis users and non-users with in the justice system were compared. They 
found that heavy cannabis users had about two times an increased record of arrest than 
non-users.  On average, the mean and median of arrest in heavy adolescent cannabis users 
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were 6.5, and 4 respectively, while the mean and median of arrest in light/non-users were 
4.5 and 3, accordingly.  In addition, the likelihood of arrest at a younger age for heavy 
cannabis users was more than for light/non-cannabis users. The mean age of first arrest 
for heavy users was 21.4 years compared to 22.5 years for light/non-users. They noted 2 
to 3 times more rates of arrest for three different kinds of crimes including violent, 
property, and drugs in heavy cannabis users than in light/non-users.  
They add that the rate of arrest for violent crime in heavy cannabis users was 31.5 
percent, almost two times higher than light/non-users (17.8%). Similarly, the rate of 
arrest for property crime in heavy cannabis users was 40.5%, two times more than that of 
light/non-users (21.3 %). The rate of arrest was two times higher (28.7%) for drug related 
crime in heavy cannabis users than in light/non-users (10.3%). They found similar 
patterns in self-reported crime; they established that around 60 percent of heavy cannabis 
users reported being involved in violent crime compared to 45 percent of light/non-users. 
Approximately, 70 percent of heavy cannabis users were involved in property crime 
compared to 47 percent of light/non-users. They also found that the involvement of heavy 
cannabis users in drug dealing was around 30 percent compared to approximately 12.3 
percent of light/non-users. Likewise, they determined that around 42 percent of heavy 
cannabis users had a record of incarceration compared to 16.6 percent of light/non-users 
(K. M. Green et al., 2010).  
2.7 Cannabis Use and Education Attainment  
 
The use of cannabis and its association with educational attainment has been 
studied. Many studies have explored the importance of the relationship of cannabis use 
and the scope of educational attainment. The link of cannabis use and low educational 
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performance including lower grade point average, low school satisfaction, negative 
attitudes to school, increased rates of school absenteeism and poor school performance, 
have been observed in majority of these cross sectional studies (Lynskey & Hall, 2000). 
The association of cannabis use and poor educational performance cannot be validated 
based on these studies because most of these studies were cross sectional.   However, the 
relationship of cannabis use and poor educational performance has also been found in 
many prospective longitudinal studies. Several prospective longitudinal studies have 
indicated the link between cannabis use and poor educational performance including 
early school dropout. Even after controlling for several confounding, this link has 
remained stable.  Several possible mechanisms have been postulated by experts for 
cannabis use and poor educational attainment. One of these mechanisms can be 
“motivational syndrome” or other cognitive and memory problems, which is caused by 
cannabis use. However, there is little evidence to support these hypotheses. Another 
reason for cannabis use and poor educational attainment can be that of the social context 
within which cannabis is used. For instance, cannabis use can be linked with an anti-
conventional life-style characterized by bonding with criminal and substance users peers 
which subsequently leads to early school leaving, run away from parental home and early 
parenthood (Lynskey & Hall, 2000). 
In another study by Fergusson and his colleagues  (2003) cannabis use was 
associated with premature school withdrawal without being able to graduate, inability to 
get into university and getting university degree. They reported that this association was 
stable even after controlling for confounding factors. “When due allowance was made for 
pre-existing levels of cannabis use there was no evidence to suggest the presence of 
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reverse causal pathways in which lower educational achievement led to increased 
cannabis use” (Fergusson et al., 2003). They concluded that their finding support the 
view of cannabis use and low educational attainment, especially, in young people. They 
propose that this effect may likely be due to social context within which cannabis used 
rather than the direct effect of cannabis on memory and cognitive ability (David M 
Fergusson et al., 2003).   
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Chapter III 
3.1 Discussion, Analysis, Intervention, Prevention and Recommendation 
 
As mentioned above cannabis use can be linked to various negative health 
outcomes, including but not limited to, increased risk of schizophrenia, psychosis, 
impaired motor control, risk of increased impairment of driving skills - with consequent 
vehicle crashes; negative education attainment, and increased rate of crime. However, 
there are few studies available to relate these outcomes to cannabis use in Afghanistan. 
Nonetheless, we can extrapolate the negative outcome of cannabis use in Afghanistan 
from the following facts: 
According to UNODC cannabis survey (2009) the prevalence of cannabis use in 
2009 in Afghanistan was 8.1 % and 0.2 % in male and female, respectively. Likewise, it 
is estimated that over two million people are suffering from schizophrenia, depression, 
and bipolar disorder in Afghanistan (WHO 2009-2013). Schizophrenia and substance use 
are the most diagnosed disorders in mental hospitals in Afghanistan (WHO 2004). In 5 
community-based psychiatric inpatient units available in the country, schizophrenia 
composed  45 % of patients and mood disorders 21% of patients with unknown 
admission length ( Afghanistan WHO AIMS Report ).    
“The distribution of diagnoses varied across facilities: in outpatients facilities 
neurotic disorders and other disorders were most prevalent, within inpatient units’ 
schizophrenia and substance abuse were most frequent diagnose in mental hospitals 
(Afghanistan WHO AIMS Report ). 
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Source:- ( Afghanistan WHO AIMS Report ) 
 
Due to the scarcity of data and research, it is difficult to quantify cannabis use as a 
cause for schizophrenia and other mental problems in Afghanistan; however, we can 
deduce from prevalence of cannabis use and increased prevalence of diagnosis of 
schizophrenia in Afghanistan that cannabis use has may likely be linked with increased 
risk of mental illness such as schizophrenia. The better measures can be drawn from 
subsequent changes in cannabis use and the estimate of schizophrenia in this country.  
Arseneault and his colleague (2004) indicate that prospective studies find that 
cannabis use is linked with two times an increase in the odds of developing schizophrenia 
and associated disorders. Considering this finding, cannabis use may likely create a major 
mental health problem for the armed forces of Afghanistan, because according to a 
Government Accountability Office report for the United States Congress in March 2010 
the prevalence of cannabis  and opiate use in Afghan Police recruits was 12 to 41 percent 
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(Nordland & Wafa, 2010). It is a major concern for the Afghan defense and interior 
ministries, because it shows that cannabis use is five time more common in Afghan 
police than in general population. It has been shown that cannabis use can result in brief 
psychotic experiences, such as hallucinations and paranoia, even in healthy individuals 
(A Complex Link Between Marijuana and Schizophrenia - TIME ). In view of this 
phenomenon, the health consequences of cannabis use in armed forces would be 
significant risk factor for irregular behavior.  
During the last several years, evidence has shown the increasing incidence rate of 
attacks, also known as “green on blue attacks” or “insider attacks”, of Afghan security 
forces including Afghan National Army and Afghan National Police on US and NATO 
forces in Afghanistan. From 2007 to 2012, there have been 71 documented “green-on-
blue” attacks. “It is difficult to draw definitive conclusions about the principal causes of 
these attacks given the small total number of incidents, but there are discernible trends” 
(Afghanistan: Green-on-Blue Attacks in Context, Institute for the Study of War ). Few 
studies have been done so far to explore the cause of these attacks, however, the use of 
cannabis and consequent psychotic symptoms such as hallucination and paranoia, have 
not been excluded.  
In addition, increased cannabis production and easy availability, even its 
handiness in grocery shops in most part of the country, has increased in the number of 
cannabis users, especially, amongst drivers. According to some unofficial surveys, more 
than 70 percent of drivers (i.e., public transport, private taxi, and truck drivers) are 
addicted to cannabis. Studies have shown that dose related cannabis use has been linked 
to the impairment of psychomotor function, actual driving performance, and vehicle 
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crashes. Similarly, Afghanistan vehicle crashes claim several hundred lives annually, 
which is a significant cause of death following the ongoing war in this country. From July 
2012  to June 2013 around 214 people have been killed and around 218 people have been 
injured due to vehicle crashes in Afghanistan (Afghanistan Accident - Crash Reports). 
There are insufficient studies to show the link between cannabis and vehicle crashes and 
subsequent mortality and morbidity in Afghanistan. However, considering the highest 
prevalence of cannabis use amongst drivers and the significant impacts of cannabis use 
on driving skills, the likelihood of a link between cannabis use and vehicle crashes in 
Afghanistan cannot be ruled out. Research is needed to explore the link between cannabis 
and vehicle crashes and related mortality and morbidity in Afghanistan.  
Likewise, the association between cannabis use and crime and educational 
attainment is also not fully explored in Afghanistan. However, evidence suggests that 
there are links between cannabis use and increased crime rates. Due to ongoing turmoil in 
Afghanistan, cannabis use may likely have significant impacts on increasing the crime 
rate and low education attainment, especially, amongst 20 to 28 years old individuals. 
The Afghanistan population literacy rate is 28.1%. The male literacy rate is 43.1%  
and the female  literacy rate is 12.6 (CIA - The World Factbook). This means that more 
than two third of Afghans are illiterate and cannabis use might likely have had its 
contribution in this process which has been unmapped. This is very important to measure 
the impact of cannabis use on educational attainment in Afghanistan.  Moreover, Studies 
are needed to measure the increased rate of crime and low education attainment amongst 
young adult in connection with cannabis use.  
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3.2 Recommendation 
 
In order to mitigate cannabis production, use, and its health consequences in 
Afghanistan, multi-approach strategies need to be adopted by various governmental and 
non-governmental entities, including the ministry of counternarcotic, ministry of health 
and ministry of defense. This multi-approach process can be applied through the 
following recommendations:- 
1. Public education programs can play an important role in the control of illicit drugs, 
especially, in the control of cannabis. As 2/3 of the population in Afghanistan are 
illiterate and are unable to appreciate the adverse outcome of cannabis use; therefore, 
they are health professionals, public health workers, religious scholars, such as Imams 
(Mullahs) and tribal elders, who can increase awareness concerning the negative health 
outcomes of cannabis.  
2. Health workers can present evidence based ill effects of cannabis on health and they may 
change the common view concerning cannabis use and the disadvantages, and thus 
playing a positive role in cannabis harm reduction.  
3. Most people, especially, in remote districts, do not consider cannabis as harmful 
substance and even educated people have little information about the relationship of 
cannabis use and mental illnesses, such as psychosis, depression and anxiety. In order to 
educate people concerning the adverse outcomes of cannabis use; media need to be 
involved in this process and need to spread the message. This approach can be 
implemented in cities through print and digital media while in remote district where such 
facilities are not available, radio, religious scholar such as Imams (Mullahs) and local 
heads of the areas can be included as role players in propagation of the message.  
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4. Spreading of messages through prominent figures, such as tribal elders and Imams 
(Mullah), can be effective for reducing cannabis production and use. In a cannabis survey 
in Afghanistan by UNODC (2011) the majority of farmers, who had ceased cannabis 
cultivation, were convinced that cannabis cultivation was Haram (taboo) in Islam. 
Twenty one percent of farmers, who ceased cannabis cultivation in 2011, were convinced 
that its cultivation was harm (banned in Islam), 19 % left cannabis cultivation due to 
government ban while 7% quit cannabis farming due to tribal elders encouragement 
(UNODC 2011). So, if Imams are employed in this process and provided with a monthly 
regular salary, it would significantly reduce the production and use of cannabis in 
Afghanistan. The salary of these Imams would be a trivial amount in comparison for the 
fund spent each year in campaigns for counternarcotic efforts in Afghanistan. At the same 
time tribal elders and Afghan government ban on the illicit drug can also help to mitigate 
cannabis and narcotics production and use in Afghanistan.   
5. Drug screen regulation should be enacted both for the new recruits to arm forces of 
Afghanistan and for drivers prior to issuing them driving license. This screening should 
include urine and blood tests for narcotics and illicit drugs. In addition, drug and 
psychiatric history should also be included in these screenings. Those who test positive 
should not be employed or issued a driving license. They need to be treated properly 
before recruitment and referred for proper counseling.  
6. Teachers and parents can also play a positive role in cannabis use reduction, especially, in 
teenagers. First teachers and parents need to be educated by health professionals and 
public health workers about the negative health consequences of cannabis use. Based on 
this awareness teachers can monitor students’ performance in schools and they can work 
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to gather with parents for the evaluation of students’ poor performance. If necessary they 
can seek help from health professions. Parents can also play a major role in control or 
prevention of cannabis use in their children. Parents need to establish a constructive 
relationship with their children and need to discuss the issues of cannabis and smoking 
with their children. They also need to monitor their children peers and their habits and 
activities.  
3.3 Summary and Conclusion  
 
Afghanistan will become worlds the major cannabis producing country (UNODC, 
Afghanistan Cannabis survey 2009). The prevalence of cannabis use in Afghanistan is 8.1 
in male and 0.2 present in female (UNODC, Afghanistan Cannabis survey 2009). 
Cannabis is widely used amongst police and army recruits as well as amongst public 
transport drivers. According to Nordland & Wafa, (2010), 12-40 percent of Afghan 
Police recruits tested positive for drug use which included marijuana, hashish and opiates. 
Based on unofficial surveys, more than 70 percent of public transports drivers who are 
driving on major highways are addicted to cannabis and other illicit drugs. Cannabis use 
can be linked to various negative health outcomes, including but not limited to, increased 
risk of schizophrenia, psychosis (hallucination and paranoia), impaired motor control and 
consequent impairment of driving skills, negative educational attainment, and increased 
crime rate; however, there are few studies available to measure the health consequences 
of cannabis in Afghanistan. Despite data unavailability, observations indicate the highest 
use of cannabis amongst drivers and increased rate of incidence of vehicle crashes, 
increased use of cannabis and hostility in Afghan soldiers and their attacks on the their 
local and international counter parts, and poor education attainment amongst students and 
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security issues in cannabis plagued areas. There is a dire need for studies and research in 
this domain for the evaluation of cannabis use and its health consequences in 
Afghanistan.  
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